[go: up one dir, main page]

TW201613602A - Pharmaceutical product - Google Patents

Pharmaceutical product

Info

Publication number
TW201613602A
TW201613602A TW104131862A TW104131862A TW201613602A TW 201613602 A TW201613602 A TW 201613602A TW 104131862 A TW104131862 A TW 104131862A TW 104131862 A TW104131862 A TW 104131862A TW 201613602 A TW201613602 A TW 201613602A
Authority
TW
Taiwan
Prior art keywords
aqueous composition
pharmaceutical product
solvate
inhibiting
salt
Prior art date
Application number
TW104131862A
Other languages
English (en)
Other versions
TWI686198B (zh
Inventor
Shin Sugimoto
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55581239&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW201613602(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kowa Co filed Critical Kowa Co
Publication of TW201613602A publication Critical patent/TW201613602A/zh
Application granted granted Critical
Publication of TWI686198B publication Critical patent/TWI686198B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Wrappers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW104131862A 2014-09-25 2015-09-25 醫藥品 TWI686198B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014194965 2014-09-25
JP2014-194965 2014-09-25

Publications (2)

Publication Number Publication Date
TW201613602A true TW201613602A (en) 2016-04-16
TWI686198B TWI686198B (zh) 2020-03-01

Family

ID=55581239

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104131862A TWI686198B (zh) 2014-09-25 2015-09-25 醫藥品

Country Status (13)

Country Link
US (1) US20170266080A1 (zh)
EP (1) EP3199162B1 (zh)
JP (6) JP6236167B2 (zh)
KR (2) KR101860279B1 (zh)
CN (1) CN107073012A (zh)
BR (1) BR112017006148A2 (zh)
CA (1) CA2962624C (zh)
ES (1) ES2909876T3 (zh)
MX (1) MX389304B (zh)
MY (1) MY179721A (zh)
SG (1) SG11201702299SA (zh)
TW (1) TWI686198B (zh)
WO (1) WO2016047720A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069421A (zh) * 2016-04-22 2018-12-21 乐敦制药株式会社 眼科组合物
TWI743107B (zh) * 2016-04-22 2021-10-21 日商樂敦製藥股份有限公司 容器與眼科組成物之組合

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6244038B2 (ja) * 2014-09-25 2017-12-06 興和株式会社 医薬製剤
JP2017197524A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
JP7125250B2 (ja) * 2016-04-22 2022-08-24 ロート製薬株式会社 眼科組成物
JP7153999B2 (ja) * 2016-04-22 2022-10-17 ロート製薬株式会社 水性組成物
JP2017197526A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
JP7159501B1 (ja) * 2016-04-22 2022-10-24 ロート製薬株式会社 眼科組成物
JP7387835B2 (ja) * 2016-04-22 2023-11-28 ロート製薬株式会社 眼科組成物
JP2017226651A (ja) * 2016-06-15 2017-12-28 興和株式会社 水性なる組成物
EP3590514A4 (en) * 2017-02-28 2021-01-06 Kowa Company, Ltd. PHARMACEUTICAL PREPARATION
WO2018159701A1 (ja) * 2017-02-28 2018-09-07 興和株式会社 医薬
EP3590515A4 (en) * 2017-02-28 2020-12-23 Kowa Company, Ltd. DRUG PRODUCT
EP3603642B1 (en) 2017-03-27 2024-01-10 Alcon Inc. Pharmaceutical preparation
WO2019167183A1 (ja) * 2018-02-28 2019-09-06 興和株式会社 医薬品製剤
JP2020193174A (ja) * 2019-05-29 2020-12-03 興和株式会社 水性組成物
JP7595233B1 (ja) 2024-07-22 2024-12-05 興和株式会社 医薬
JP7635471B1 (ja) 2024-09-12 2025-02-25 興和株式会社 医薬製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718797B2 (en) * 2004-03-16 2010-05-18 Asahi Kasei Pharma Corporation Fasudil-containing preparation and method of improving stability thereof
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
JP2006290827A (ja) * 2005-04-13 2006-10-26 Kowa Co 緑内障予防又は治療剤
JP4800720B2 (ja) * 2005-09-21 2011-10-26 興和株式会社 点眼用組成物
US20080064681A1 (en) * 2006-09-11 2008-03-13 Hiroyoshi Hidaka Therapeutic agent for treating glaucoma
KR20110022686A (ko) * 2008-07-25 2011-03-07 아사히 가세이 파마 가부시키가이샤 술폰아미드 화합물을 함유하는 안정적인 수용액 조성물
WO2015156321A1 (ja) * 2014-04-09 2015-10-15 ロート製薬株式会社 眼科組成物
JP6244038B2 (ja) * 2014-09-25 2017-12-06 興和株式会社 医薬製剤
KR20170093836A (ko) * 2014-12-12 2017-08-16 코와 가부시키가이샤 조성물

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069421A (zh) * 2016-04-22 2018-12-21 乐敦制药株式会社 眼科组合物
CN109069421B (zh) * 2016-04-22 2021-10-12 乐敦制药株式会社 眼科组合物
TWI743107B (zh) * 2016-04-22 2021-10-21 日商樂敦製藥股份有限公司 容器與眼科組成物之組合
US11331390B2 (en) 2016-04-22 2022-05-17 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition

Also Published As

Publication number Publication date
SG11201702299SA (en) 2017-04-27
JP2021107462A (ja) 2021-07-29
MY179721A (en) 2020-11-11
MX389304B (es) 2025-03-20
JPWO2016047720A1 (ja) 2017-06-29
CN107073012A (zh) 2017-08-18
KR20170063572A (ko) 2017-06-08
JP2018021077A (ja) 2018-02-08
BR112017006148A2 (pt) 2017-12-26
TWI686198B (zh) 2020-03-01
KR101860279B1 (ko) 2018-05-21
CA2962624A1 (en) 2016-03-31
EP3199162A4 (en) 2018-04-25
JP2019199483A (ja) 2019-11-21
JP2023041805A (ja) 2023-03-24
EP3199162A1 (en) 2017-08-02
EP3199162B1 (en) 2022-03-09
WO2016047720A1 (ja) 2016-03-31
US20170266080A1 (en) 2017-09-21
CA2962624C (en) 2022-08-30
JP6236167B2 (ja) 2017-11-22
KR20180021929A (ko) 2018-03-05
MX2017003943A (es) 2017-06-30
ES2909876T3 (es) 2022-05-10
JP2024160370A (ja) 2024-11-13

Similar Documents

Publication Publication Date Title
TW201613602A (en) Pharmaceutical product
WO2016011390A8 (en) Irak4 inhibiting agents
PH12016500169A1 (en) Polymorph of syk inhibitors
IL311677B1 (en) History of bicyclic heterocyclyls as IRAK4 inhibitors
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
MY194116A (en) Pharmaceutical compounds
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
HK1231416A1 (zh) 西羅莫司及其衍生物的絡合物、其製備方法以及含有其的藥物組合物
TW201613603A (en) Pharmaceutical preparation
WO2016071435A3 (en) Synthesis of copanlisib and its dihydrochloride salt
MY178881A (en) Novel aqueous composition
MX2017007574A (es) Composicion.
EP3283453A4 (en) COATINGS AND ADDITIVES WITH FATTY ACIDS, SALTS OF FATTY ACIDS OR SIMILAR COMPOUNDS FOR USE AS DROPS AND / OR DECLARING AGENTS FOR GRANULAR PRODUCTS
MY176921A (en) Tetrazolone-substituted dihydropyridinone mgat2 inhibitors
IL260040A (en) Complexes of celecoxib and its salts and derivatives, a process for their preparation and pharmaceutical preparations containing them
MX2017007572A (es) Composicion acuosa.
AU2016248025B2 (en) Polymorphs of AFATINIB and its salts and process for the preparation of quinazolinyl derivatives
MX2020012771A (es) Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
WO2015191681A3 (en) Substituted pyridinones as mgat2 inhibitors
AU2015280874A1 (en) Novel heterocyclic compound
WO2017214423A3 (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof
EP3353149A4 (en) PROCESS FOR THE PREPARATION OF INDOLIN COMPOUNDS AND A NOVEL INDOLIN SALT
WO2015102024A3 (en) Novel substituted 5 membered heterocyclic compounds and preparation thereof
WO2016057660A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
EP3436439A4 (en) METHOD FOR PRODUCING DIPHENYLPYRAZINE DERIVATIVES

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees